Caris Life Sciences, Inc. · Brief

Next report

4 days

Nov 4 · after closeconfirmedQ3 FY26

Expected move

±10.8%implied · report alone

30.6338.03

straddle ±16.7%

spot 34.33exp Nov 20ATM strike 35ATM straddle 6.75IV 102%

Oct 30 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±19.9%▲+21.58%×1.09

quarterimplied−25%0+25%realized×

Q2 FY26±19.9%▲+21.58%×1.09

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · confirmed

Bull2

18disclosed supplier and customer tiesSEC filings

247managers reporting a position in the latest quarter13F · Jun 30 '26

Bear2 of 3

21managers holding most of reported value13F · Jun 30 '26

5 of 22largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 19 '26once per report · top 2 per case

CAI report session

No linked exposure.

Oct 21impliedImplied move: ±17.3% into Nov 4 earnings (Oct 21 close).Source

Oct 15report dateEarnings date confirmed: Nov 4, after close.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.